13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001600004
Total reported value
$1.6B
$1.6B
35 檔
27.8%
The Q1 2026 SEC filing reveals that First Light Asset Management, LLC held a total portfolio value of $1.6B, covering 35 public equity positions.
In Q1 2026, First Light Asset Management, LLC adopted a defensive or profit-taking posture, trimming 19 positions and completely liquidating 5 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AXGN | Axogen Inc | Stock-Other | 11.88% | -4.16% | -23.51% | |
| 2 | PVLA | Palvella Therapeutics Inc | Stock-Other | 10.96% | -3.79% | +38.30% | |
| 3 | NEO | Neogenomics Inc | Stock-Healthcare | 6.47% | +4.42% | -3.04% | |
| 4 | SIBN | Si-bone Inc | Stock-Other | 6.06% | +2.00% | +6.36% | |
| 5 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 5.56% | -5.56% | EXIT | |
| 6 | APGE | Apogee Therapeutics Inc | Stock-Other | 4.35% | +3.15% | +102.35% | |
| 7 | AMLX | Amylyx Pharmaceuticals Inc | Stock-Other | 3.97% | -0.67% | -4.91% | |
| 8 | TWST | Twist Bioscience CORP | Stock-Other | 3.74% | +0.81% | -22.96% | |
| 9 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 3.55% | -0.45% | -8.76% | |
| 10 | MASS | 908 Devices Inc | Stock-Other | 3.33% | -0.01% | +25.57% | |
| 11 | NPCE | Neuropace Inc | Stock-Other | 2.90% | -0.14% | +82.29% | |
| 12 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 2.83% | -0.13% | -36.34% | |
| 13 | ANAB | Anaptysbio Inc | Stock-Other | 2.81% | -0.42% | -12.50% | |
| 14 | SLP | Simulations Plus Inc | Stock-Other | 2.79% | +0.32% | +33.72% | |
| 15 | GH | Guardant Health Inc | Stock-Healthcare | 2.32% | +1.71% | -4.90% | |
| 16 | TNDM | Tandem Diabetes Care Inc | Stock-Other | 2.26% | +0.84% | +20.67% | |
| 17 | ATRC | Atricure Inc | Stock-Other | 1.87% | -0.90% | -37.94% | |
| 18 | TLSI | Trisalus Life Sciences Inc | Stock-Other | 1.82% | -0.01% | — | |
| 19 | TECX | Tectonic Therapeutic Inc | Stock-Other | 1.79% | -0.12% | — | |
| 20 | IRTC | Irhythm Holdings Inc | Stock-Healthcare | 1.78% | -0.57% | +9.26% | |
| 21 | SEPN | Septerna Inc | Stock-Other | 1.58% | +0.38% | +18.05% | |
| 22 | ✓ | Establishment Labs Holdings In | Stock-Other | 1.57% | -0.28% | -17.51% | |
| 23 | HCAT | Health Catalyst Inc | Stock-Other | 1.47% | +0.08% | -0.25% | |
| 24 | OMCL | Omnicell Inc | Stock-Healthcare | 1.47% | -0.33% | — | |
| 25 | KRMD | Koru Medical Systems Inc | Stock-Other | 1.46% | -0.60% | -10.50% | |
| 26 | WGS | Genedx Holdings CORP | Stock-Other | 1.40% | +1.87% | — | |
| 27 | WVE | Wave Life Sciences Ltd. | Stock-Other | 1.20% | -1.20% | EXIT | |
| 28 | VERA | Vera Therapeutics Inc | Stock-Other | 1.13% | -1.13% | EXIT | |
| 29 | MDXG | Mimedx Group Inc | Stock-Other | 1.01% | -1.01% | EXIT | |
| 30 | BFLY | Butterfly Network Inc | Stock-Other | 0.96% | +0.39% | -5.40% | |
| 31 | SGP | Spyglass Pharma Inc | Stock-Other | 0.87% | -0.87% | EXIT | |
| 32 | ORGO | Organogenesis Holdings Inc | Stock-Other | 0.74% | -0.74% | EXIT | |
| 33 | PCVX | Vaxcyte Inc | Stock-Other | 0.74% | +0.48% | — | |
| 34 | ELVN | Enliven Therapeutics Inc | Stock-Other | 0.71% | +3.49% | — | |
| 35 | RYTM | Rhythm Pharmaceuticals Inc | Stock-Other | 0.68% | -0.10% | -70.53% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | PVLA | Palvella Therapeutics Inc | +5.3% | +38.30% | Add |
| 2 | APGE | Apogee Therapeutics Inc | +2.7% | +102.35% | Add |
| 3 | MASS | 908 Devices Inc | +1.4% | +25.57% | Add |
| 4 | NPCE | Neuropace Inc | +1.3% | +82.29% | Add |
| 5 | 260 | Centessa Pharmaceuticals-adr | +1.2% | -31.50% | Trim |
| 6 | TWST | Twist Bioscience CORP | +1% | -22.96% | Trim |
| 7 | AMLX | Amylyx Pharmaceuticals Inc | +0.9% | -4.91% | Trim |
| 8 | TNDM | Tandem Diabetes Care Inc | +0.4% | +20.67% | Add |
| 9 | ANAB | Anaptysbio Inc | +0.4% | -12.50% | Trim |
| 10 | SEPN | Septerna Inc | +0.3% | +18.05% | Add |
| 11 | BFLY | Butterfly Network Inc | +0.1% | -5.40% | Trim |
| 12 | SLP | Simulations Plus Inc | +0.1% | +33.72% | Add |
| 13 | GH | Guardant Health Inc | 0% | -4.90% | Trim |
| 14 | EWTX | Edgewise Therapeutics Inc | -0.2% | -36.34% | Trim |
| 15 | IRTC | Irhythm Holdings Inc | -0.3% | +9.26% | Add |
| 16 | KRMD | Koru Medical Systems Inc | -0.4% | -10.50% | Trim |
| 17 | ✓ | Establishment Labs Holdings In | -0.5% | -17.51% | Trim |
| 18 | MDXG | Mimedx Group Inc | -0.6% | -6.46% | Trim |
| 19 | CRNX | Crinetics Pharmaceuticals In | -0.7% | -8.76% | Trim |
| 20 | ORGO | Organogenesis Holdings Inc | -0.8% | -9.43% | Trim |
| 21 | HCAT | Health Catalyst Inc | -0.9% | -0.25% | Trim |
| 22 | WVE | Wave Life Sciences Ltd. | -1.2% | -0.53% | Trim |
| 23 | AXGN | Axogen Inc | -1.2% | -23.51% | Trim |
| 24 | SIBN | Si-bone Inc | -1.5% | +6.36% | Add |
| 25 | ATRC | Atricure Inc | -1.7% | -37.94% | Trim |
| 26 | RYTM | Rhythm Pharmaceuticals Inc | -1.7% | -70.53% | Trim |
| 27 | VERA | Vera Therapeutics Inc | -2.2% | -63.91% | Trim |
| 28 | NEO | Neogenomics Inc | -2.6% | -3.04% | Trim |
| 29 | IRON | Disc Medicine Inc | — | EXIT | Sold out |
| 30 | MDGL | Madrigal Pharmaceuticals Inc | — | EXIT | Sold out |
| 31 | TLSI | Trisalus Life Sciences Inc | — | NEW | New buy |
| 32 | TECX | Tectonic Therapeutic Inc | — | NEW | New buy |
| 33 | OMCL | Omnicell Inc | — | NEW | New buy |
| 34 | WGS | Genedx Holdings CORP | — | NEW | New buy |
| 35 | ABVX | Abivax Sa-adr | — | EXIT | Sold out |
| 36 | SGP | Spyglass Pharma Inc | — | NEW | New buy |
| 37 | PCVX | Vaxcyte Inc | — | NEW | New buy |
| 38 | ELVN | Enliven Therapeutics Inc | — | NEW | New buy |
| 39 | DYN | Dyne Therapeutics Inc | — | EXIT | Sold out |
| 40 | IWO | Ishares Russell 2000 Growth | — | EXIT | Sold out |
According to official SEC Form 13F filings, First Light Asset Management, LLC reported a total U.S. public equity portfolio value of $1.6B across 35 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including AXGN, PVLA, NEO) accounted for 27.8% of total reported equity market value during Q1 2026.
Top New Position Initiated
TLSI
市值: $20.3M
Top Position Liquidated / Trimmed
IRON
前期市值: $41.5M
During Q1 2026, First Light Asset Management, LLC's top holdings by market value included AXGN (11.9%)、PVLA (11.0%)、NEO (6.5%). The largest single position, AXGN, represented 11.9% of total portfolio value.
In Q1 2026, First Light Asset Management, LLC made 40 total portfolio adjustments, initiating 7 new buys, adding to 9 positions, trimming 19 holdings, and fully liquidating 5 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.